US assesses attack risk preparedness

NEW YORK – The scene: Terrorists release pneumonic plague in two counties in northern New Jersey while launching a chemical weapon attack in New London, Connecticut.

As a result, the New York Health Department expects 1,744 New Yorkers to succumb to the disease, the Jersey City financial district experiences up to a 45% no-show by its employees and the US markets open sharply down. It’s not the latest summer movie blockbuster, it’s the test scenario for Topoff 3, the US Department of Homeland Security’s (DHS) third congressionally mandated weapons of mass destruction (WMD) national exercise.

The test ran from April 4 to April 8 and involved more than 10,000

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here